Liver Metastasis in Cancer: Molecular Mechanisms and Management

Wenchao Xu1,2,3,4, Jia Xu5, Jianzhou Liu1,2,3,4

  • 1Department of General Surgery Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Medcomm
|March 3, 2025
PubMed

Insights

Liver metastasis, a major cause of cancer death, involves distinct stages of the liver

Area of Science:

  • Oncology
  • Hepatology
  • Immunology

Background:

  • Liver metastasis is a primary driver of cancer mortality, complicating treatment efficacy.
  • Tumor cells from various origins share common pathways for liver colonization and growth.
  • The liver possesses inherent characteristics that facilitate metastatic processes.

Purpose of the Study:

  • To review the molecular mechanisms and therapeutic strategies for liver metastasis.
  • To elucidate the distinct phases of liver metastasis based on the liver's response.
  • To highlight the role of cellular interactions and immune microenvironment in liver metastasis.

Main Methods:

  • Review of preclinical and clinical research on liver metastasis.
  • Analysis of molecular mechanisms driving tumor cell colonization and growth in the liver.
  • Examination of host-pathogen interactions and immune cell spatial remodeling.

Main Results:

  • Liver metastasis progresses through three distinct phases: sensing, stress, and support.
  • Intricate interactions between metastatic cells and liver-resident/recruited cells are crucial.
  • Spatial remodeling of immune cells significantly influences liver metastasis progression.

Conclusions:

  • Understanding the stages of liver metastasis is key to developing effective treatments.
  • Future antimetastatic therapies must address individual heterogeneity and stage-specific interventions.
  • Targeted interventions based on the distinct phases of liver metastasis are essential for improved outcomes.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K